IRIS
LUCARELLI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.213
NA - Nord America 1.787
EU - Europa 1.413
SA - Sud America 262
AF - Africa 67
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.746
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.706
SG - Singapore 950
RU - Federazione Russa 718
VN - Vietnam 458
CN - Cina 429
BR - Brasile 201
IT - Italia 177
HK - Hong Kong 136
DE - Germania 126
FR - Francia 95
GB - Regno Unito 93
NL - Olanda 71
IN - India 58
FI - Finlandia 44
CA - Canada 36
AR - Argentina 32
KR - Corea 32
JP - Giappone 29
MX - Messico 28
BD - Bangladesh 19
ZA - Sudafrica 19
CI - Costa d'Avorio 18
PH - Filippine 14
PL - Polonia 13
TH - Thailandia 13
UA - Ucraina 11
AT - Austria 10
IQ - Iraq 10
TR - Turchia 10
PK - Pakistan 9
ES - Italia 8
ID - Indonesia 8
CZ - Repubblica Ceca 6
EC - Ecuador 6
EG - Egitto 6
LT - Lituania 6
SE - Svezia 6
UZ - Uzbekistan 6
DK - Danimarca 5
IR - Iran 5
MA - Marocco 5
PY - Paraguay 5
CL - Cile 4
CO - Colombia 4
IE - Irlanda 4
JO - Giordania 4
LV - Lettonia 4
NP - Nepal 4
VE - Venezuela 4
AU - Australia 3
CH - Svizzera 3
IL - Israele 3
JM - Giamaica 3
KE - Kenya 3
KG - Kirghizistan 3
PA - Panama 3
PE - Perù 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AZ - Azerbaigian 2
BE - Belgio 2
BG - Bulgaria 2
BS - Bahamas 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
NG - Nigeria 2
NI - Nicaragua 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
AL - Albania 1
AM - Armenia 1
BO - Bolivia 1
BW - Botswana 1
BZ - Belize 1
CD - Congo 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GM - Gambi 1
GR - Grecia 1
HR - Croazia 1
IM - Isola di Man 1
KZ - Kazakistan 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
ML - Mali 1
MW - Malawi 1
MY - Malesia 1
NE - Niger 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UG - Uganda 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
YT - Mayotte 1
Totale 5.746
Salva come PNG Salva come JPEG
Città #
Singapore 476
San Jose 333
Ashburn 203
Moscow 162
Hefei 137
Hong Kong 132
Chandler 126
Ho Chi Minh City 119
Beijing 115
Hanoi 91
Santa Clara 72
Naples 65
Amsterdam 63
Munich 58
Dong Ket 56
The Dalles 52
Los Angeles 51
Lauterbourg 47
Enfield 41
New York 32
Millbury 31
Frankfurt am Main 27
Turku 26
Kochi 25
Redondo Beach 25
Seoul 25
Tokyo 25
Dallas 24
Lawrence 24
Des Moines 22
Boston 21
Buffalo 19
Haiphong 19
São Paulo 19
London 18
Phoenix 18
Da Nang 16
Orem 14
Council Bluffs 12
Mexico City 12
Chicago 11
Helsinki 11
Johannesburg 11
Milan 11
Montreal 11
Ottawa 11
Seattle 11
Warsaw 11
Bari 9
Chennai 9
Napoli 9
Nuremberg 9
Biên Hòa 8
Brooklyn 8
Houston 8
Wilmington 8
Denver 7
Lappeenranta 7
Paris 7
Baghdad 6
Düsseldorf 6
Fairfield 6
Ha Long 6
Nanjing 6
Ninh Bình 6
Pune 6
Vienna 6
Ankara 5
Belo Horizonte 5
Cairo 5
Can Tho 5
Guangzhou 5
Kronberg 5
Poplar 5
Princeton 5
Shanghai 5
Toronto 5
Amman 4
Atlanta 4
Bangkok 4
Bexley 4
Boardman 4
Bắc Giang 4
Concepción 4
Dearborn 4
Dhaka 4
Dublin 4
Manchester 4
Riga 4
San Francisco 4
Siziano 4
Stockholm 4
Tashkent 4
Woodbridge 4
Augusta 3
Bengaluru 3
Brasília 3
Cambridge 3
Campinas 3
Casablanca 3
Totale 3.214
Salva come PNG Salva come JPEG
Nome #
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets 207
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor 171
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials 167
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis 156
Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort Analysis 153
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 152
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update 151
The Impact of Meat Intake on Bladder Cancer Incidence: Is It Really a Relevant Risk? 146
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 146
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer 144
Epigenetic signature: A new player as predictor of clinically significant prostate cancer (PCa) in patients on active surveillance (AS) 142
Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management-Current Trends and Future Perspectives 142
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study 141
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 141
Urinary long noncoding RNAs in nonmuscle-invasive bladder cancer: new architects in cancer prognostic biomarkers 140
Beyond PSA: The Role of Prostate Health Index (phi) 140
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings 139
Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade 3 bladder cancer 137
The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial 133
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer 132
Integration of lipidomics and transcriptomics reveals reprogramming of the lipid metabolism and composition in clear cell renal cell carcinoma 132
Prostate cancer radiogenomics—from imaging to molecular characterization 127
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette–Guerin Immunotherapy 126
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG 125
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 125
Liquid biopsy biomarkers in urine: A route towards molecular diagnosis and personalized medicine of bladder cancer 125
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies 123
The evolving landscape of renal surgery for complex renal masses (CRM): implications for oncologic and functional outcomes 122
Novel Key Ingredients in Urinary Tract Health-The Role of D-mannose, Chondroitin Sulphate, Hyaluronic Acid, and N-acetylcysteine in Urinary Tract Infections (Uroial PLUS®) 122
Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review 122
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer 121
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer 121
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 120
SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study 119
Radiomics in prostate cancer: an up-to-date review 118
Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies 118
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy 115
Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice 106
Surgical blood loss during holmium laser enucleation of the prostate (HoLEP) is not affected by short-term pretreatment with dutasteride: a double-blind placebo-controlled trial on prostate vascularity 102
Quality of Web-Based Patient Information on Robotic Radical Cystectomy Remains Poor: A Standardized Assessment 98
Percutaneous Ablation vs Robot-Assisted Partial Nephrectomy for Completely Endophytic Renal Masses: A Multicenter Trifecta Analysis with a Minimum 3-Year Follow-Up 76
Molecular Imaging Diagnosis of Renal Cancer Using 99mTc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel Techniques 75
Radiogenomics in Renal Cancer Management-Current Evidence and Future Prospects 70
Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer 65
Current Management of Urachal Carcinoma: An Evidence-based Guide for Clinical Practice 62
Radiotherapy to the Primary Tumor: The First Step of a Tailored Therapy in Metastatic Prostate Cancer 57
Microwave versus cryoablation and radiofrequency ablation for small renal mass: a multicenter comparative analysis 50
Totale 5.822
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.119
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.119
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202166 0 0 0 0 0 0 0 0 0 0 4 62
2021/2022189 7 3 4 0 2 2 1 3 6 22 70 69
2022/2023436 29 11 16 7 50 38 1 41 60 128 53 2
2023/2024290 6 55 60 22 16 15 5 38 5 2 51 15
2024/20251.649 64 80 0 11 53 61 160 88 133 221 654 124
2025/20263.069 339 288 354 311 495 143 391 154 355 182 57 0
Totale 5.822